Survival from cancer in teenagers and young adults in England, 1979–2003
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6604460.pdf
Reference24 articles.
1. Alston RD, Rowan S, Eden TOB, Moran A, Birch JM (2007) Cancer incidence patterns by region and socioeconomic deprivation in teenagers and young adults in England. Brit J Cancer 96: 1760–1766
2. Barr RD, Holowaty EJ, Birch JM (2006) Classification schemes for tumors diagnosed in adolescents and young adults. Cancer 106: 1425–1430
3. Birch JM, Alston RD, Kelsey AM, Quinn MJ, Babb P, McNally RJ (2002) Classification and incidence of cancers in adolescents and young adults in England 1979–1997. Br J Cancer 87 (11): 1267–1274
4. Birch JM, Alston RD, Quinn M, Kelsey AM (2003) Incidence of malignant disease by morphological type in young persons aged 12–24 years in England, 1979–1997. Eur J Cancer 39: 2622–2631
5. Bleyer A, Budd T, Montello M (2007) Older adolescents and young adults with cancer and clinical trials: lack of participation and progress in North America. In: Cancer in Adolescents and Young Adults. Chapter 5, pp 71–81
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Transition between paediatric and adult diabetes healthcare services: An online global survey of healthcare professionals’ experiences and perceptions;Diabetes Research and Clinical Practice;2024-08
2. The Impact of Specialist Care on Teenage and Young Adult Patient-Reported Outcomes in England: A BRIGHTLIGHT Study;Journal of Adolescent and Young Adult Oncology;2024-06-01
3. Surgery in platinum-resistant recurrent epithelial ovarian carcinoma;World Journal of Clinical Cases;2022-04-26
4. Disparities in economic burden for children with leukemia insured by resident basic medical insurance: evidence from real-world data 2015–2019 in Guangdong, China;BMC Health Services Research;2022-02-19
5. Brentuximab vedotin in combination with bendamustine in pediatric patients or young adults with relapsed or refractory Hodgkin lymphoma;Pediatric Blood & Cancer;2022-02-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3